http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29161733

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 132
issn 1671-4083
1745-7254
issueIdentifier 1
pageRange 121-132
publicationName Acta Pharmacologica Sinica
startingPage 121
bibliographicCitation Zhao Z, Jiang Y, Chen Y, Wu T, Lan Q, Li Y, Li L, Yang Y, Lin C, Cao Y, Zhou P, Guo J, Tian Y, Pang J. CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia. Acta Pharmacologica Sinica. 2021 Mar 25;43(1):121–32. doi: 10.1038/s41401-021-00640-5.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16972f7de72d755b3226e39a9476206d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3d34db5af0982553e63441e1bc0f08d5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1d2499fb9172a5496553242cb295ff5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8bd13946015fda6a3afec81b06112193
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa958aa58ee8fbb27ef0207b83d68a4f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58d3f118cd8418c222fdda669e2e439b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3266cd8dd5b963241274f8ea3b9a5390
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_71f102abe7751540e5c4cd97a2c00303
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44d774f3e13ff1d646976597257146c0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4dab3c2c980b88563382b4a2d20f7a43
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f1fb1aa483f62381f682bb5c9a36e82
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a0c37dcaa713af32dce94edd06833b7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1f66761068634c2805cda42bdcf808e
date 2021-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/33767379
https://doi.org/10.1038/s41401-021-00640-5
https://pubmed.ncbi.nlm.nih.gov/PMC8724292
isPartOf https://portal.issn.org/resource/ISSN/1671-4083
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22029
https://portal.issn.org/resource/ISSN/1745-7254
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia
discusses http://id.nlm.nih.gov/mesh/M0019167
http://id.nlm.nih.gov/mesh/M0460542
http://id.nlm.nih.gov/mesh/M0076804
http://id.nlm.nih.gov/mesh/M0380850
http://id.nlm.nih.gov/mesh/M0014037
http://id.nlm.nih.gov/mesh/M0367610
http://id.nlm.nih.gov/mesh/M000758231
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bd45b9ce9c4159fa707937f7c37b234f
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54767229
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10751
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1175
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fa6ecc398d38a031f6c5566b88350ebf
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723920
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123164
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d5714431f6dd7517db52178ecfa6d8d1

Total number of triples: 53.